Whanin Pharmaceutical Co., Ltd. logo

Whanin Pharmaceutical Co., Ltd. (016580)

Market Open
11 Aug, 06:30
KRX SM KRX SM
10,390. 00
+40
+0.3865%
173.74B Market Cap
- P/E Ratio
1,200% Div Yield
35,880 Volume
- Eps
10,350
Previous Close
Add Transaction
Day Range
10,390 10,390
Year Range
9,160 12,140
Want to track 016580 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Whanin Pharmaceutical Co., Ltd. (016580) Statistics

Valuation metrics

Market Cap 173.74B
Enterprise value 134.38B
Trailing P/E (ttm) 9.24
Forward P/E -
PEG ratio 1.98
Price/Sales (ttm) 0.7
Price/Book (mrq) 0.46
Enterprise Value/Revenue 0.49
Enterprise Value/EBITDA 4.92

Overview

Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 68.17K
Average volume (90 days) 45.3K

Price summary

52-Week low 9,160
52-Week high 12,140
Beta -
50-Day moving average 9,851.14
200-Day moving average 10,435.78

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 300
Trailing annual dividend yield 0.0288%
5-Year annual dividend yield -
Payout ratio 0.22
Dividend Date 16 Apr 2026
Ex-Dividend Date 29 Dec 2025
Last split factor 2:1
Last split Date 14 Apr 2010

Financials

Fiscal year

Fiscal year ends -
Most recent quarter (mrq) -

Profitability

Profit margin 0.07%
Operating margin 0.08%

Operational effectiveness

Return on assets 0.04%
Return on equity 0.05%

Income Statement

Revenue (ttm) -
Revenue per share (ttm) 14,702.96
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 1,097.01
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) -
Total cash per share (mrq) 3,408.17
Total debt (mrq) -
Total Debt/Equity (mrq) 0
Current ratio (mrq) 4.1%
Book value per share (mrq) 22,803.36

Cash Flow

Cash flow statement -
Levered free cash flow (LFCF) -